Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
- Conditions
- ALS
- Interventions
- Other: Observation
- Registration Number
- NCT03366506
- Lead Sponsor
- Hadassah Medical Organization
- Brief Summary
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-
1. Differences between ethnic subgroups
2. Differences between immigrant and native-born populations
3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.
- Detailed Description
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-
1. Differences between ethnic subgroups
2. Differences between immigrant and native-born populations
3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.
The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction.
Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2000
- Suspected, possible, probable ,definite ALS
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description ALS patients Observation ALS patients ( suspected, possible, probable or definite per El-Escorial criteria). Observation
- Primary Outcome Measures
Name Time Method Progression rate up to 10 years Progression of ALSFRS-R score over time
- Secondary Outcome Measures
Name Time Method Appearance of clinical features of UMN or LMN dysfunction 10 years Appearance of clinical features of UMN or LMN dysfunction over time
Trial Locations
- Locations (1)
Hadassah Medical Organisation
🇮🇱Jerusalem, Israel